Benjamin Edwards’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
Benjamin Edwards's PACB Position: Q3 2026 in Review
Benjamin Edwards reduced its Pacific Biosciences (PACB) stake by 3.7% in Q3 2026, selling an estimated $5.68K and leaving 103,695 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #1333.
Benjamin Edwards first reported a position in PACB in Q4 2021 and has held it in 20 quarters since. The position peaked at $303K in Q4 2024. 146 funds tracked by Wall St. Rank hold PACB as of Q3 2026.
- Benjamin Edwards held 103,695 shares of Pacific Biosciences worth $246K as of Q3 2026.
- Benjamin Edwards sold 4,020 Pacific Biosciences shares in Q3 2026, an estimated $5.68K.
- Pacific Biosciences made up ﹤0.01% of Benjamin Edwards's portfolio in Q3 2026, its #1333 holding.
- Benjamin Edwards first reported a position in Pacific Biosciences in Q4 2021 and has held it in 20 quarters since.
- Benjamin Edwards's Pacific Biosciences position peaked at $303K in Q4 2024.
- 146 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.
Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.